Effects of the Consumption of SEAweed Biomass Versus PROtein Isolates on Postprandial Satiety and Metabolism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-20

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a need to identify alternative sources of protein that can be introduced into diets to effectively meet the protein requirements of the population. Seaweed presents a potential source of sustainable, alternative protein. In order to determine their utility in future foods, in this study we will undertake an acute postprandial trial to explore whether a macroalgae (porphyra) and a microalgae (chlorella) protein isolates are more beneficial for acute metabolic health as compared to their respective whole biomasses. In particular, we will compare the effects of whole biomasses and their protein isolates on acute glucose homeostasis, amino acid availability as well as on satiety and gut hormones.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome

NCT05343858

Metabolic Syndrome

COMPLETED NA

Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human

NCT00936754

Glycemic Index

COMPLETED PHASE1

Seaweed Iodine Delivered Via Food or Supplementation

NCT04875377

Iodine Deficiency

COMPLETED NA

Seaweed, the Food Matrix, and Iodine Bioavailability

NCT04867291

Iodine Bioavailability

UNKNOWN NA

Age Related Effects Consuming Phaeodactylum Tricornutum

NCT05120791

Aging Well Aging

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Seaweed presents a potential source of sustainable, alternative protein. Broadly categorised into macroalgae and microalgae, macroalgae including those of the genus Porphyra are traditionally known as nori or laver and is a common ingredient in several Asian dishes such as soups and sushi. Porphyra is rich in protein, micronutrients and dietary fibre and the equivalent variety in New Zealand is a red macroalgae known as Karengo. A prominent genus of microalgae is Chlorella, which is a green microalgae also rich in protein and currently used mainly in dietary supplements. The interest in seaweed as an ingredient incorporated into meals, food products and dietary supplements has been growing due to their macronutrient composition and bioactive substances with studied health benefits including improvements in glucose homeostasis, appetite and anti-hypertensive and hypocholesterolemic properties.

However, controlled human studies comparing specific macroalgae and microalgae, particularly for their potential to be used as a source of alternative protein, has been limited. Therefore, the present study aims to compare macroalgae (Porphyra) biomass and its protein isolates versus microalgae (Chlorella) biomass and its protein isolates on postprandial satiety and nutrient metabolism in healthy adult Chinese males by adding these as ingredients to a noodle soup dish. We specifically aim to explore whether the protein isolates are superior to the respective whole biomasses in terms of glucose homeostasis, amino acid availability as well as in terms of satiety and gut hormones. Results from this study will be used towards future food applications to enhance the potential of the use of seaweed as a sustainable and nutritious source of alternative proteins.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition, Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Non-blinded, randomised crossover trial with each participant testing 5 different test ingredients on 5 separate study sessions on 5 days.

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Soy-based control meal

Bowl of soup noodles prepared with 10g soy protein isolate soup base and consumed with a pack of plain crackers (approximately 65g available carbohydrate in total).

Group Type ACTIVE_COMPARATOR

Soy control

Intervention Type OTHER

Soy isolate control meal

Laver/nori macroalgae (Porphyra umbilicus) whole biomass-based treatment meal

Bowl of soup noodles prepared with 10g Laver/nori macroalgae (Porphyra umbilicus) whole biomass soup base and consumed with a pack of plain crackers (approximately 65g available carbohydrate in total).

Group Type EXPERIMENTAL

Intervention (Laver/nori (Porphyra umbillicus) macroalgae whole biomass)

Intervention Type OTHER

Laver/nori (Porphyra umbillicus) macroalgae whole biomass treatment meal

Laver/nori macroalgae (Porphyra umbilicus) protein isolates-based treatment meal

Bowl of soup noodles prepared with 10g Laver/nori macroalgae (Porphyra umbilicus) protein isolates soup base and consumed with a pack of plain crackers (approximately 65g available carbohydrate in total).

Group Type EXPERIMENTAL

Intervention (Laver/nori macroalgae (Porphyra umbillicus) protein isolates)

Intervention Type OTHER

Laver/nori macroalgae (Porphyra umbillicus) protein isolates treatment meal

Microalgae (Chlorella vulgaris) whole biomass-based treatment meal

Bowl of soup noodles prepared with 10g microalgae (Chlorella vulgaris) whole biomass soup base and consumed with a pack of plain crackers (approximately 65g available carbohydrate in total).

Group Type EXPERIMENTAL

Intervention (Chlorella microalgae (Chlorella vulgaris) whole biomass)

Intervention Type OTHER

Chlorella microalgae (Chlorella vulgaris) whole biomass treatment meal

Microalgae (Chlorella vulgaris) protein isolates-based treatment meal

Bowl of soup noodles prepared with 10g microalgae (Chlorella vulgaris) protein isolates soup base and consumed with a pack of plain crackers (approximately 65g available carbohydrate in total).

Group Type EXPERIMENTAL

Intervention (Chlorella microalgae (Chlorella vulgaris) protein isolates)

Intervention Type OTHER

Chlorella microalgae (Chlorella vulgaris) protein isolates treatment meal

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Soy control

Soy isolate control meal

Intervention Type OTHER

Intervention (Laver/nori (Porphyra umbillicus) macroalgae whole biomass)

Laver/nori (Porphyra umbillicus) macroalgae whole biomass treatment meal

Intervention Type OTHER

Intervention (Laver/nori macroalgae (Porphyra umbillicus) protein isolates)

Laver/nori macroalgae (Porphyra umbillicus) protein isolates treatment meal

Intervention Type OTHER

Intervention (Chlorella microalgae (Chlorella vulgaris) whole biomass)

Chlorella microalgae (Chlorella vulgaris) whole biomass treatment meal

Intervention Type OTHER

Intervention (Chlorella microalgae (Chlorella vulgaris) protein isolates)

Chlorella microalgae (Chlorella vulgaris) protein isolates treatment meal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male
* Chinese ethnicity
* Aged 21 to 50 years
* Able to give informed consent
* Body Mass Index (BMI) of 18.5 to 25.0 kg/m2

Exclusion Criteria

* Diabetic (HbA1C ≥ 6.5%)
* Smoking
* Having a dislike towards seaweed- or soy-based products
* Having allergies or intolerances to any common food ingredients including seaweed, soy, eggs, seafood, fish, milk, peanuts, tree nuts, wheat, gluten, cereal, fruits, dairy products, meat, vegetables, sugar, sweeteners, natural food colourings or flavourings, etc.
* Following special diets or having intentional dietary restrictions (e.g, vegetarians/vegans)
* Not willing to adhere to diet modification as in the study protocol
* Taking part in strenuous physical activities
* Not willing to stop any strenuous activity during or within 24 hours of study days (for those actively participating in sports at the competitive and/or endurance levels)
* Having glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
* Having alcohol consumption on \> 4 days per week with ≥ 6 alcoholic drinks per week
* Having sustained elevation of blood pressure (≥140/90 mm Hg)
* Having previously undergone any gastrointestinal surgery or having history of gastrointestinal disorders
* Having a history of heart, liver, kidney, blood disorders (e.g., thalassemia) or thyroid dysfunctions
* Having history of tuberculosis, HIV, Hepatitis B or Hepatitis C infections
* Having any prescription medication or any other alternative medicines or supplements which may interfere with study measurements in the opinion of the study investigators
* Having donated blood within 4 weeks of study participation
* Having poor veins or having history of severe vasovagal syncope (blackouts or fainting) from blood draws

Minimum Eligible Age

21 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes